Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022
Bioventus (BVS) will announce its Q3 fiscal results on November 8, 2022, before market opening. A conference call is scheduled for 8:30 a.m. ET on the same day to discuss the results and provide a business update. Interested participants can join by dialing 1-833-636-0497 domestically or +1-412-902-4241 internationally. A live webcast and materials will be accessible through the Investor Relations section of Bioventus' website, with archived availability until November 7, 2023.
- None.
- None.
DURHAM, N.C., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2022 before the market opens on Tuesday, November 8, 2022. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
To participate in the conference call, dial 1-833-636-0497 (domestic) or +1-412-902-4241 (international) and refer to the Bioventus, Inc. Conference Call.
A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until November 7, 2023.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com
FAQ
When will Bioventus report its Q3 2022 earnings?
What time is the Bioventus conference call for Q3 results?
How can I participate in the Bioventus conference call?
Where can I find the Bioventus Q3 earnings call webcast?